Companies: 10,795·Total market cap: $144.5T

Nuvation Bio Inc.

Nuvation Bio Inc.

NUVBNYSEHealthcare● Active

$4.80

$-0.03(-0.52%)

Market Cap$1.7B

P/E Ratio—

52W High$9.75

52W Low$1.57

Avg Volume4.0M

Open$4.91

Beta1.56

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Nuvation Bio Inc.（NUVB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NUVB · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.42Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$143.0MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding341.5MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Nuvation Bio Inc. 数据

分析师预测$13 · Buy

股息不分红

营收$62.9M+698.96%

盈利EPS $-0.60+71.56%

财务快照

FY 2025Revenue$62.9M▲ +698.96% YoY

202320242025

FY 2025Net Income-$204.6M▲ +63.97% YoY

202320242025

FY 2025EPS$-0.60▲ +71.56% YoY

202320242025

TTM:Revenue: $143.0MNet Income: -$146.0MEPS: $-0.42View income statement →

分析师评级与目标价

Buy9 位分析师

Strong Buy

0

Buy

7

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$10.00Low

$4.79Current

$13.00Avg Target上涨空间 171.12%

$17.00High

合计: 9 · 买入占比: 77.8%

根据过去 3 个月内 9 位华尔街分析师，NUVB 共识评级为 Buy，12 个月平均目标价 $13.00 （较现价 $4.79 上涨空间 171.12%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Nuvation Bio Inc.

$4.80-0.52%$1.7B #2

AbCellera Biologics Inc.

$5.39-3.04%$1.6B #3

Aurinia Pharmaceuticals Inc.

$15.78-0.73%$2.0B #4

Celldex Therapeutics, Inc.

$28.52-0.07%$1.9B #5

Edgewise Therapeutics, Inc.

$34.91-2.36%$3.8B #6

Structure Therapeutics Inc.

$36.92-2.42%$2.1B

股票表现

1D+0.31%

1W-0.31%

1M+0.94%

3M+5.34%

YTD-46.04%

1Y+92.63%

5Y-64.26%

关于 Nuvation Bio Inc.

CEODavid T. Hung

IPO DateAug 26, 2020

Employees273

CountryUS

Websitenuvationbio.com

Nuvation Bio Inc. a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhi…

Biotechnology HealthcareNYSEUS

关于股票概览与关键数据

Nuvation Bio Inc.（NUVB）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 26, 2020 在 NYSE 上市。截至最近交易日，NUVB 股价为 $4.79，市值约为 $1.7B。过去12个月累计回报 +92.63%，年初至今回报 -46.04%。

根据 9 位华尔街分析师，Nuvation Bio Inc. 股票共识评级为Buy，12个月平均目标价为 $13.00。2025 财年 Nuvation Bio Inc. 营收 $62.9M，净利润 -$204.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Nuvation Bio Inc.（NUVB）股价为 $4.79，在 NYSE 上市，52周区间为 $1.57 – $9.75。

NUVB 最新股价NUVB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议